PETV
PetVivo Holdings, Inc. [PETV] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PETV Stock Summary
Top 10 Correlated Stocks
PETV
In the News
PETV Financial details
Company Rating
-
Market Cap
16.25M
Income
-10.63M
Revenue
1.05M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
25
Optionable
No
Shortable
Yes
Earnings
27 Jun 2024
P/E
-1.35
Forward P/E
-
PEG
-0.24
P/S
17.48
P/B
15.24
P/C
-
P/FCF
-2.08
Quick Ratio
0.11
Current Ratio
1.05
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.87
EPS next Y
-
EPS next Q
-
EPS this Y
51.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.77%
Revenue last 5Y
63.74%
Revenue Q/Q
187.36%
EPS Q/Q
-57.14%
-
-
-
-
SMA20
-1.79%
SMA50
-21.43%
SMA100
12.24%
Inst Own
-
Inst Trans
-
ROA
-275%
ROE
-1545%
ROC
-4.89%
Gross Margin
43%
Oper. Margin
-1092%
Profit Margin
-1165%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.55-2.95
52W High
-
52W Low
-
RSI
61.34
Rel Volume
0.23
Avg Volume
36.7K
Volume
8.6K
Perf Week
20.96%
Perf Month
14.36%
Perf Quarter
25.8%
Perf Half Y
18.68%
-
-
-
-
Beta
2.1
-
-
Volatility
0.04%, 0.04%
Prev Close
8.45%
Price
0.629
Change
12.32%
Company Profile
- Volume Average 36.7K
- Market Capitalization 16.25M
- Employee 25
- CEO Mr. John Lai
- Headquarters Minneapolis,MN,US
- IPO Date 2014-09-08
-
Website
https://www.petvivo.com 
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
